Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Drugs Made In America Acquisition Corp. Ordinary Shares operates in the Shell Companies industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $10.71, down 0.05% on the session, giving a market capitalisation of $259.9M. On trailing twelve-month figures it carries a trailing P/E of 52.32, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Drugs Made In America Acquisition Corp. Ordinary Shares is most often compared with the following Financial Services names: